Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ainos, Inc. stock logo
AIMD
Ainos
$0.50
+3.7%
$0.55
$0.40
$1.07
$10.48M2.2245,292 shs258,441 shs
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
$0.20
$0.17
$2.96
$13M-25.93N/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$3.43
+1.8%
$5.14
$3.00
$107.40
$1.51M-1.178,725 shs48,575 shs
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
$6.90
-2.7%
$6.99
$5.35
$30.03
$25.39M-2165,906 shs77,449 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ainos, Inc. stock logo
AIMD
Ainos
0.00%-1.07%-25.90%+1.79%-38.54%
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
0.00%0.00%0.00%0.00%-82.29%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.00%-9.74%-20.33%-64.73%+342,999,900.00%
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
0.00%+1.77%+15.38%-28.08%-75.76%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ainos, Inc. stock logo
AIMD
Ainos
0.9191 of 5 stars
0.04.00.00.01.41.70.6
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/AN/AN/AN/AN/AN/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.8193 of 5 stars
0.04.00.00.02.00.80.6
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
1.7795 of 5 stars
3.32.00.00.02.60.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ainos, Inc. stock logo
AIMD
Ainos
0.00
N/AN/AN/A
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
0.00
N/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.00
N/AN/AN/A
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
2.50
Moderate Buy$30.00334.78% Upside

Current Analyst Ratings Breakdown

Latest AIMD, TPST, CHHE, and SHPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$16.00 ➝ $16.00
4/10/2025
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Outperform ➝ Sector Perform$7.00 ➝ $9.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ainos, Inc. stock logo
AIMD
Ainos
$20K524.00N/AN/A$1.10 per share0.45
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
$110K0.00N/AN/A$0.60 per share0.00
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/A$4.35 per shareN/A
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
N/AN/AN/AN/A$5.66 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ainos, Inc. stock logo
AIMD
Ainos
-$14.86M-$1.29N/AN/AN/A-88.07%-48.60%8/4/2025 (Estimated)
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
-$410K-$0.020.00N/AN/AN/AN/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-$9.15M-$4.15N/AN/AN/A-1,203.10%-370.42%N/A
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
-$41.84M-$17.98N/AN/AN/AN/A-305.51%-119.74%8/6/2025 (Estimated)

Latest AIMD, TPST, CHHE, and SHPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
-$3.71-$3.16+$0.55-$3.16N/AN/A
5/12/2025Q1 2025
Ainos, Inc. stock logo
AIMD
Ainos
N/A-$0.21N/A-$0.21N/A$0.11 million
5/8/2025Q1 2025
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/A-$7.50N/A-$0.30N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ainos, Inc. stock logo
AIMD
Ainos
N/AN/AN/AN/AN/A
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/AN/AN/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/AN/A
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ainos, Inc. stock logo
AIMD
Ainos
0.84
2.00
1.91
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/A
2.78
2.78
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
N/A
1.70
1.70

Institutional Ownership

CompanyInstitutional Ownership
Ainos, Inc. stock logo
AIMD
Ainos
N/A
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
N/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
4.58%
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
22.52%

Insider Ownership

CompanyInsider Ownership
Ainos, Inc. stock logo
AIMD
Ainos
10.39%
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
31.30%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
12.60%
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
4.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ainos, Inc. stock logo
AIMD
Ainos
4020.96 million18.78 millionNot Optionable
China Health Industries Holdings, Inc. stock logo
CHHE
China Health Industries
4064.95 million44.62 millionNot Optionable
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
5440,000384,000Not Optionable
Tempest Therapeutics, Inc. stock logo
TPST
Tempest Therapeutics
203.68 million3.51 millionOptionable

Recent News About These Companies

TPST - Tempest Therapeutics Inc Valuation - Morningstar
TPST Tempest Therapeutics, Inc. - Seeking Alpha
Tempest Therapeutics

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ainos stock logo

Ainos NASDAQ:AIMD

$0.50 +0.02 (+3.69%)
As of 06/27/2025 04:00 PM Eastern

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

China Health Industries stock logo

China Health Industries OTCMKTS:CHHE

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.

Shuttle Pharmaceuticals stock logo

Shuttle Pharmaceuticals NASDAQ:SHPH

$3.43 +0.06 (+1.78%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$3.46 +0.02 (+0.73%)
As of 04:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.

Tempest Therapeutics stock logo

Tempest Therapeutics NASDAQ:TPST

$6.90 -0.19 (-2.68%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$7.02 +0.13 (+1.81%)
As of 04:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.